Navigating Adverse Reactions in GLP-1 Treatment

This episode explores the mechanisms underlying GLP-1 adverse reactions, strategies to minimize GI side effects, and patient-specific factors influencing tolerability. Nicole Snow discusses monitoring and titration approaches tailored to individual patient responses, while Judith Hey-Hadavi emphasizes integrating safety data with clinical decision-making and the importance of managing expectations. Both speakers highlight how dosing, prior exposure, and patient physiology contribute to the overall safety profile of GLP-1 therapies.